Abstract
Escherichia coli is an important cause of both community acquired (CA) and hospital acquired (HA) bacteremia. A prospective study was conducted at a tertiary care University Hospital from January, 2012 to July 2014, to compare the clinical features, risk factors, outcomes and antimicrobial resistance between E. coli bacteremia acquired from the community (CA) versus E. coli bacteremia acquired from the hospital (HA). Clinical and laboratory data of 171 adult patients with at least one positive blood culture of E. coli were analyzed. Data were collected from patients with significant blood stream infection, using medical and laboratory record files and information from treating medical staff. The overall incidence of extended spectrum beta lactamase (ESBL) infection was high, 67/171 (77.4%). Thirty-eight (40.9%) of the CA isolates were found to produce ESBL, while 28 (35.9%) of the HA isolates were ESBL producers. Patients with CA bacteremia tend to be older than those with HA bacteremia (0.003). Neoplastic diseases (hematological malignancy (<0.001), solid tumors (<0.001)), renal transplantation end stage renal disease (ESRD) (<0.006), and wound infection (<0.001) were the most commonly associated conditions in patients with HA bacteremia. Patients from the community are more likely to present with UTI (<0.001), fever and pyelonephritis (0.001). Both CA and HA E. coli isolates showed the highest sensitivity to imipenem, meropenem and amikacin followed by gentamicin and tazocin. The CA isolates are more susceptible to amikacin, tazocin and ciprofloxacin than the HA isolates. No significant difference in the mortality rate between patients with CA bacteremia and patients who acquire the bacteremia in a hospital setting (0.836) was observed. Clinicians need to be aware of the risk factors and changing pattern of antimicrobial resistance of this pathogen and should consider adequate empirical therapy with coverage of these pathogens for patients with risk factors Key words: Escherichia coli, community acquired, hospital acquired, bacteremia, blood stream infection.
Highlights
Escherichia coli are part of the normal gastrointestinal flora and a leading cause of Gram negative bacteremia (Tenaillon et al, 2010)
E. coli-blood stream infection is a major cause of morbidity and mortality with a relatively high associated population burden (Pitout et al, 2004; Uslan et al, 2007; Williamson et al, 2013)
communi ty acquired (CA) and hospital acquired (HA) E. coli blood stream infection (Pitout et al, 2004; Rodríguez-B año et al, 2010) such populationbased demographic information is important in implementing strategies for treatment and prevention of these serious infections
Summary
Escherichia coli are part of the normal gastrointestinal flora and a leading cause of Gram negative bacteremia (Tenaillon et al, 2010). In the first study (ElKhizzi and Bakheshwain, 2006), different patient populations with nosoc omial and community-acquired infections were assessed, the majority (83%) of the ESBL-producing isolates were E. coli. A recent study on the characteristics of hospital-acquired and community-onset blood stream infections from Austria (Hoenigl et al, 2014), E. coli followed by Staphylococcus aureus were the most frequently isolated pathogens.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
